Suchergebnisse - "Fang, Wei-Tse"

PubPharm (23)

1

Real-world evidence of lorlatinib therapy in Taiwanese patients with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer

enthalten in: Journal of the Formosan Medical Association = Taiwan yi zhi | 2024

von Shih, J. | Luo, Y. | Chang, G. | +5

2

Cost-utility analysis of inotuzumab ozogamicin for relapsed or refractory B cell acute lymphoblastic leukemia from the perspective of Taiwan's health care system

enthalten in: The European journal of health economics : HEPAC : health economics in prevention and care | 2020

von Lee, T. | Chen, H. | Chen, T. | +5

3

Comparing the effectiveness of different EGFR-TKIs in patients with EGFR mutant non-small-cell lung cancer : A retrospective cohort study in Taiwan

enthalten in: International journal of cancer | 2020

von Hsieh, Y. | Fang, W. | Lo, Y. | +2

4

Cost-utility analysis of inotuzumab ozogamicin for relapsed or refractory B cell acute lymphoblastic leukemia from the perspective of Taiwan’s health care system

enthalten in: The European journal of health economics | 2020

von Lee, T. | Chen, H. | Chen, T. | +5

5

Cost-utility analysis of inotuzumab ozogamicin for relapsed or refractory B cell acute lymphoblastic leukemia from the perspective of Taiwan’s health care system

enthalten in: The European journal of health economics | 2020

von Lee, T. | Chen, H. | Chen, T. | +5

6

Cost-utility analysis of inotuzumab ozogamicin for relapsed or refractory B cell acute lymphoblastic leukemia from the perspective of Taiwan’s health care system

enthalten in: The European journal of health economics | 2020

von Lee, T. | Chen, H. | Chen, T. | +5

7

Reply to "Use DN4-T to rule out non-neuropathic pain"

enthalten in: Journal of the Chinese Medical Association : JCMA | 2020

von Wang, Y. | Yang, C. | Ro, L. | +5

CommentOn: J Chin Med Assoc. 2019 Aug;82(8):623-627. - PMID 31169589

8

Cost-utility analysis of inotuzumab ozogamicin for relapsed or refractory B cell acute lymphoblastic leukemia from the perspective of Taiwan's health care system

Erschienen: 2020

von Lee, T. | Chen, H. | Chen, T. | +5

9

Comparing the effectiveness of different EGFR‐TKIs in patients with EGFR mutant non–small‐cell lung cancer : A retrospective cohort study in Taiwan

enthalten in: International Journal of Cancer | 2020

von Hsieh, Y. | Fang, W. | Lo, Y. | +2

10

Development and validation of a Taiwan version of the DN4-T questionnaire

enthalten in: Journal of the Chinese Medical Association : JCMA | 2019

von Wang, Y. | Yang, C. | Ro, L. | +5

CommentIn: J Chin Med Assoc. 2020 May;83(5):511. - PMID 32217987